"Spot-Light" Sheds New Light on Breast Cancer - KCBD NewsChannel 11 Lubbock

7/8/08

"Spot-Light" Sheds New Light on Breast Cancer

The FDA has approved a new test that may help determine which breast cancer patients will benefit from certain drugs. 

The test is called "Spot-Light" and it can determine how many "Her-2" genes there are in a tumor.  Her-2 genes manage the growth of cancer cells.  Doctors know that when a patient has too many of them cancer grows and divides more quickly.  The new test uses chemicals to make the Her-2 genes change color allowing doctors to see whether a patient needs special treatment for that.

Spot-Light is manufactured by Invitrogen Corp. of Carlsbad, California.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.